Although sales in Europe and North America are slowing, Reckitt Benckiser executives insist that sales will rise at the upper end of its target this year after reporting second-quarter revenue that topped analysts’ estimates. For the second quarter, sales rose 7% to $3.8 billion at current exchange rates. For the six months, sales rose 7% to more than $7.6 billion. Non-pharmaceutical revenue will advance at the upper end of the 5-6% guidance the company had previously disclosed, the Slough, ...